EUVIMEDEUVIMED entdecken
Open Access

Outcomes and Risk Factors for Postoperative Vasoplegia Following Implant of Left Ventricular Assist Devices

Jonathan C Wright iD, Jameson G Wilbur, Shane S Scott iD, Yasaman Navari iD, Mahmoud Abdel-Rasoul iD, Bryan A Whitson iD, Sakima A Smith iD

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.043366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Jonathan C Wright und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Ohio State University Wexner Medical Center Columbus OH USA. Hauptthemen laut MEDLINE: Heart-Assist Devices, Vasoplegia, Heart Failure, Postoperative Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postoperative vasoplegia syndrome (PVS) following cardiac surgery has previously been associated with poor survival. This study aimed to investigate outcomes and predictors of PVS following left ventricular assist device implantation.

Methods

This was a retrospective study of 190 left ventricular assist device recipients at The Ohio State University. Primary outcomes included hospitalization duration, right‐sided heart failure, and mortality. Risk factor evaluation included multivariate analysis of cardiovascular comorbidities and perioperative medication use. Patients were stratified into PVS (n=50, 26.3%) and non‐PVS cohorts.

Results

On univariate analysis, PVS was associated with male sex (94% versus 67%, P =0.0004) and higher body mass index (32.5 versus 29.0, P =0.0011). Further, PVS was associated with diabetes (60.0% versus 41.4%, P =0.036), higher preoperative hemoglobin A 1c levels (6.8% versus 6.3%, P =0.0354), and higher rates of microvascular complications (28.0% versus 12.9%, P =0.014). Preoperatively, patients without PVS were more likely to receive dobutamine (58.6% versus 34.0%, P =0.004) and at higher dosages (2.9 versus 1.9 μg/kg per min, P =0.0196). Primary outcomes, including mortality, were similar between groups. Multivariate analysis demonstrated male sex (odds ratio [OR], 9.43 [95% CI, 2.93–43.6]) and higher body mass index (OR, 1.11, [95% CI, 1.04–1.18]) as independent risk factors. HeartMate 3 implantation (OR, 0.33 [95% CI, 0.10–0.97]) and preimplant dobutamine infusion (OR, 0.28 [95% CI, 0.12–0.61]) were protective factors.

Conclusions

PVS did not confer inferior outcomes after left ventricular assist device implantation but was associated with male sex and higher body mass index. Preoperative dobutamine was more commonly used in patients without PVS, warranting further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesVasoplegiaHeart FailurePostoperative ComplicationsHumansMaleRisk FactorsRetrospective StudiesFemaleTreatment OutcomeMiddle AgedBody Mass IndexSex FactorsAgedDobutamineMultivariate AnalysisTime Factors

Stichwörter der Autor:innen

dobutamineleft ventricular assist devicemilrinoneright‐sided heart failurevasoplegia

Substanzen

Dobutamine

Autor:innen und Institutionen

  • The Ohio State University Wexner Medical Center Columbus OH USA.
  • University of Texas Southwestern Medical Center Dallas TX USA.
  • Michigan State University College of Human Medicine East Lansing MI USA.
  • Center for Biostatistics The Ohio State University College of Medicine Columbus OH USA.
  • Division of Cardiac Surgery The Ohio State University College of Medicine Columbus OH USA.
  • Frick Center for Heart Failure and Arrhythmia The Ohio State University Wexner Medicine Center Columbus OH USA.

ORCID-Profile: Jonathan C Wright, Shane S Scott, Yasaman Navari, Mahmoud Abdel-Rasoul, Bryan A Whitson, Sakima A Smith

Förderung

  • NIAID NIH HHS

Zitieren

APA

Wright, J. C., Wilbur, J. G., Scott, S. S., Navari, Y., Abdel-Rasoul, M., Whitson, B. A., & Smith, S. A. (2026). Outcomes and Risk Factors for Postoperative Vasoplegia Following Implant of Left Ventricular Assist Devices. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.043366

Vancouver

Wright JC, Wilbur JG, Scott SS, Navari Y, Abdel-Rasoul M, Whitson BA, et al. Outcomes and Risk Factors for Postoperative Vasoplegia Following Implant of Left Ventricular Assist Devices. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.043366

BibTeX
@article{Wright2026,
  author = {Wright, Jonathan C and Wilbur, Jameson G and Scott, Shane S and Navari, Yasaman and Abdel-Rasoul, Mahmoud and Whitson, Bryan A and Smith, Sakima A},
  title = {Outcomes and Risk Factors for Postoperative Vasoplegia Following Implant of Left Ventricular Assist Devices},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.043366}
}
Kostenlos starten →